Skip to main content
. Author manuscript; available in PMC: 2015 Sep 28.
Published in final edited form as: J Control Release. 2014 Apr 16;0:210–218. doi: 10.1016/j.jconrel.2014.04.014

Table 1.

Examples of Gelatin Modifications

Modification outcomes Advantages Applications
Stealth delivery
  • Reduced immunogenicity

  • Prolonged circulatory time

  • Evasion of reticuloendothelial uptake

  • PEGylated nanoparticles for pulmonary drug delivery [17, 36]

  • PEGylated/thiolated nanoparticles for intracellular DNA delivery [37]

  • PEGylated nanocarriers for anti-inflammatory drug release [28]

Enhanced drug stabilization and loading efficiency
  • Tunable hydrophobicity of the carrier

  • Higher drug encapsulation efficiency

  • More stable complexation between carrier and drug

  • Succinylated gelatin for angiogenesis [20]

  • Cationized microparticles for siRNA delivery [34, 38]

  • Hexanoyl anhydride grafted-nanoparticles for anticancer drug release [39]

Targeted drug delivery
  • Highly selective cell targeting

  • Reduced side-effects

  • Lower systemic cytotoxicity

  • Introduction of EGFR-recognition sequence for gene delivery in pancreatic cancer [40]

  • EGF-modified nanoparticles for aerosol delivery to lung cancer [35, 41]

  • PEG/peptide conjugated nanoparticles for brain drug delivery [42]